Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody

Figure 3

Patient’s total maintenance dosage of mycophenolate mofetil. Dose reductions were made to mitigate leukopenia requiring filgrastim treatment. Brief treatment interruptions were made in the setting of suspected viral gastroenteritis (postoperative day 87–91) and suspected viral bronchitis (postoperative day 227–229).